Kamada Intangible Assets Over Time

KMDA Stock  USD 7.46  0.17  2.23%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Kamada Performance and Kamada Correlation.
For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.
  
The current year's Intangible Assets is expected to grow to about 132.4 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kamada. If investors know Kamada will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kamada listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.167
Earnings Share
0.27
Revenue Per Share
2.812
Quarterly Revenue Growth
0.1
Return On Assets
0.0322
The market value of Kamada is measured differently than its book value, which is the value of Kamada that is recorded on the company's balance sheet. Investors also form their own opinion of Kamada's value that differs from its market value or its book value, called intrinsic value, which is Kamada's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kamada's market value can be influenced by many factors that don't directly affect Kamada's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kamada's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kamada is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kamada's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Intangible Assets Analysis

Compare Kamada and related stocks such as Lifecore Biomedical, Shuttle Pharmaceuticals, and Cumberland Pharmaceuticals Intangible Assets Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
2010201120122013201420152016201720182019202020212022202320242025
LFCR15 M59 M58 M57.1 M56.3 M21.4 M22.8 M21.8 M45.2 M38.1 M36.1 M15.6 M15.6 M4.2 M4.8 M4.6 M
CPIX37 KM9.5 M15.5 M21.6 M21.2 M22.2 M21.4 M33.7 M30.9 M28.1 M24 M30.6 M22.6 M26 M19.2 M
IRWD0.00.00.00.00.00.0166.1 M159.9 M3.7 M3.7 M3.7 M3.7 M3.7 M3.7 M4.2 MM
ORGO0.011.4 M11.4 M11.4 M11.4 M11.4 M11.4 M29.8 M26.1 M20.8 M30.6 M25.7 M20.8 M15.9 M18.3 M22.1 M
AKAN321.4 K321.4 K321.4 K321.4 K321.4 K321.4 K321.4 K321.4 K321.4 K321.4 K321.4 K259.1 K22.2 M3.8 M4.4 M7.3 M
EVOK0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
COLL2.1 M2.1 M2.1 M2.1 M2.1 M0.02.1 M0.044.3 M29.5 M335.9 M268.7 M567.5 M421.7 M485 M509.2 M
RDY415 K11.3 B108.3 B11.3 B13.1 B20.8 B44.9 B44.7 B44.4 B27.7 B35.6 B27.2 B30.7 B37 B42.5 B24.7 B
PCRX13.1 M5.3 M3.2 M1.2 M403 K81 K46.7 M55.2 M104.4 M104.4 M96.5 M624 M540.5 M483.3 M555.7 M583.5 M
PRGO31.7 M729.3 M1.2 B6.8 B6.9 B10.4 B3.5 B3.4 B2.9 B2.9 BB2.1 B3.2 BB3.4 B1.8 B
ANIP0.00.085 K10.4 M42.1 M66.4 M175.8 M229.8 M201.6 M180.4 M188.5 M294.1 M251.6 M209 M240.4 M156.5 M
PAHC6.3 M15 M35.2 M29.8 M37.3 M60.1 M54.6 M52 M47.5 M71 M62.3 M63.9 M55 M45 M51.8 M34.7 M
PBH292.2 M1.4 B1.4 B1.4 B2.1 B2.3 B2.9 B2.8 B2.5 B2.5 B2.5 B2.7 B2.3 B2.3 B2.7 B1.8 B
JavaScript chart by amCharts 3.21.15Macroaxis Charts2012201420162018202020222024 10B20B30B40B50B60B70B80B90B100B110B
JavaScript chart by amCharts 3.21.15Lifecore Biomedicaltotal: 475.7MCumberland Pharmaceuticalstotal: 333.4MAkanda Corptotal: 41.5MDr Reddys Laboratoriestotal: 524.1BPacira BioSciences,total: 3.2BPerrigo Company PLCtotal: 55.3BPhibro Animal Healthtotal: 721.4MPrestige Brand Holdingstotal: 33.9B

Kamada and related stocks such as Lifecore Biomedical, Shuttle Pharmaceuticals, and Cumberland Pharmaceuticals Intangible Assets description

Non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value.

My Equities

My Current Equities and Potential Positions

Kamada
KMDA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationIsrael
ExchangeNASDAQ Exchange
USD 7.1
100%
When determining whether Kamada offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kamada's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kamada Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kamada Stock:
Check out Kamada Performance and Kamada Correlation.
For information on how to trade Kamada Stock refer to our How to Trade Kamada Stock guide.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Kamada technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Kamada technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kamada trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...